vs

Side-by-side financial comparison of Cheer Holding, Inc. (CHR) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($90.3M vs $71.0M, roughly 1.3× Cheer Holding, Inc.). Cheer Holding, Inc. runs the higher net margin — 10.9% vs 0.1%, a 10.8% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs -0.1%).

Cheer Holding, Inc. is a diversified holding company primarily operating in the Chinese market, with core business segments covering early childhood education services, mobile lifestyle platforms, digital content offerings, and integrated consumer solutions for households and enterprise partners across multiple demand scenarios.

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

CHR vs EOLS — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.3× larger
EOLS
$90.3M
$71.0M
CHR
Growing faster (revenue YoY)
EOLS
EOLS
+14.5% gap
EOLS
14.4%
-0.1%
CHR
Higher net margin
CHR
CHR
10.8% more per $
CHR
10.9%
0.1%
EOLS

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CHR
CHR
EOLS
EOLS
Revenue
$71.0M
$90.3M
Net Profit
$7.8M
$130.0K
Gross Margin
70.7%
65.7%
Operating Margin
11.7%
4.7%
Net Margin
10.9%
0.1%
Revenue YoY
-0.1%
14.4%
Net Profit YoY
-37.5%
101.9%
EPS (diluted)
$0.67
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHR
CHR
EOLS
EOLS
Q4 25
$90.3M
Q3 25
$69.0M
Q2 25
$71.0M
$69.4M
Q1 25
$68.5M
Q4 24
$78.9M
Q3 24
$61.1M
Q2 24
$71.1M
$66.9M
Q1 24
$59.3M
Net Profit
CHR
CHR
EOLS
EOLS
Q4 25
$130.0K
Q3 25
$-15.7M
Q2 25
$7.8M
$-17.1M
Q1 25
$-18.9M
Q4 24
$-6.8M
Q3 24
$-19.2M
Q2 24
$12.4M
$-11.3M
Q1 24
$-13.1M
Gross Margin
CHR
CHR
EOLS
EOLS
Q4 25
65.7%
Q3 25
66.5%
Q2 25
70.7%
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
73.4%
70.3%
Q1 24
68.3%
Operating Margin
CHR
CHR
EOLS
EOLS
Q4 25
4.7%
Q3 25
-16.7%
Q2 25
11.7%
-14.7%
Q1 25
-22.1%
Q4 24
-2.9%
Q3 24
-25.3%
Q2 24
16.4%
-11.5%
Q1 24
-15.0%
Net Margin
CHR
CHR
EOLS
EOLS
Q4 25
0.1%
Q3 25
-22.8%
Q2 25
10.9%
-24.7%
Q1 25
-27.6%
Q4 24
-8.6%
Q3 24
-31.4%
Q2 24
17.5%
-17.0%
Q1 24
-22.1%
EPS (diluted)
CHR
CHR
EOLS
EOLS
Q4 25
$0.01
Q3 25
$-0.24
Q2 25
$0.67
$-0.27
Q1 25
$-0.30
Q4 24
$-0.11
Q3 24
$-0.30
Q2 24
$1.23
$-0.18
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHR
CHR
EOLS
EOLS
Cash + ST InvestmentsLiquidity on hand
$53.8M
Total DebtLower is stronger
$146.1M
Stockholders' EquityBook value
$322.1M
$-23.1M
Total Assets
$362.7M
$225.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHR
CHR
EOLS
EOLS
Q4 25
$53.8M
Q3 25
$43.5M
Q2 25
$61.7M
Q1 25
$67.9M
Q4 24
$87.0M
Q3 24
$85.0M
Q2 24
$186.1M
$93.7M
Q1 24
$97.0M
Total Debt
CHR
CHR
EOLS
EOLS
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Q1 24
$120.6M
Stockholders' Equity
CHR
CHR
EOLS
EOLS
Q4 25
$-23.1M
Q3 25
$-28.8M
Q2 25
$322.1M
$-18.7M
Q1 25
$-6.6M
Q4 24
$5.5M
Q3 24
$5.9M
Q2 24
$286.1M
$19.3M
Q1 24
$18.4M
Total Assets
CHR
CHR
EOLS
EOLS
Q4 25
$225.9M
Q3 25
$219.0M
Q2 25
$362.7M
$228.8M
Q1 25
$213.4M
Q4 24
$232.6M
Q3 24
$229.6M
Q2 24
$333.2M
$233.8M
Q1 24
$226.2M
Debt / Equity
CHR
CHR
EOLS
EOLS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×
Q1 24
6.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHR
CHR
EOLS
EOLS
Operating Cash FlowLast quarter
$3.9M
$12.8M
Free Cash FlowOCF − Capex
$11.3M
FCF MarginFCF / Revenue
12.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
0.51×
98.67×
TTM Free Cash FlowTrailing 4 quarters
$-45.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHR
CHR
EOLS
EOLS
Q4 25
$12.8M
Q3 25
$-14.7M
Q2 25
$3.9M
$-24.8M
Q1 25
$-15.6M
Q4 24
$4.8M
Q3 24
$-5.7M
Q2 24
$-6.7M
$-6.5M
Q1 24
$-10.6M
Free Cash Flow
CHR
CHR
EOLS
EOLS
Q4 25
$11.3M
Q3 25
$-15.6M
Q2 25
$-25.5M
Q1 25
$-16.0M
Q4 24
$4.4M
Q3 24
$-6.0M
Q2 24
$-6.9M
Q1 24
$-10.9M
FCF Margin
CHR
CHR
EOLS
EOLS
Q4 25
12.6%
Q3 25
-22.7%
Q2 25
-36.7%
Q1 25
-23.3%
Q4 24
5.5%
Q3 24
-9.9%
Q2 24
-10.4%
Q1 24
-18.3%
Capex Intensity
CHR
CHR
EOLS
EOLS
Q4 25
1.6%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.5%
Q4 24
0.6%
Q3 24
0.5%
Q2 24
0.7%
Q1 24
0.4%
Cash Conversion
CHR
CHR
EOLS
EOLS
Q4 25
98.67×
Q3 25
Q2 25
0.51×
Q1 25
Q4 24
Q3 24
Q2 24
-0.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons